https://www.selleckchem.com/pr....oducts/cordycepin.ht
need to identify multimodality strategies that are safe and capable of prolonging the efficacy of ketamine in adults with TRD. Hitherto, available open-label data and controlled trial data support repeat administration of IV ketamine as an effective strategy to prolong the efficacy of ketamine's antidepressant effects (although not the focus of the study herein, maintenance repeat-dose esketamine treatment is proven effective in esketamine responders). There is a need to identify multimodality strategies that are safe and capable of
Respect!
Kommentar
Delen
